Anti-agalactosyl immunoglobulin G antibodies in localized scleroderma

International Journal of Dermatology

Volumn 44, Issue 10, 2005, Pages 817-820

  Mimura, Yoshihiro ^a   Ihn, Hronobu ^a   Jinnin, Masatoshi ^a   Asano, Yoshihide ^a   Yamane, Kenichi ^a   Yazawa, Norihito ^a   Tamaki, Kunihiko ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AGALACTOSYL IMMUNOGLOBULIN G ANTIBODY; ANTINUCLEAR ANTIBODY; DNA ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; RHEUMATOID FACTOR; SINGLE STRANDED DNA; UNCLASSIFIED DRUG;

ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ARTICLE; BLOOD SAMPLING; CHILD; CONTROLLED STUDY; CORRELATION FUNCTION; DISEASE ACTIVITY; DISEASE MARKER; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FREQUENCY ANALYSIS; HUMAN; IMMUNOFLUORESCENCE; LINEAR SCLERODERMA; MAJOR CLINICAL STUDY; MALE; MORPHEA; STATISTICAL SIGNIFICANCE;

ADOLESCENT; ADULT; ANTIBODIES, ANTI-IDIOTYPIC; ANTIBODIES, ANTINUCLEAR; CHILD; CHILD, PRESCHOOL; DNA, SINGLE-STRANDED; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULIN G; MALE; RHEUMATOID FACTOR; SCLERODERMA, LOCALIZED;

EID: 27544509850     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2005.02584.x     Document Type: Article

References (19)

1. Tuffanelli DL, Winkelmann RK. Systemic scleroderma. Arch Dermatol 1961; 84: 359-371.
2. Takehara K, Moroi Y, Nakabayashi Y, et al. Antinuclear antibodies in localized scleroderma. Arthritis Rheum 1983; 26: 612-616.
3. Sato S, Ihn H, Soma Y, et al. Antihistone antibodies in patients with localized scleroderma. Arthritis Rheum 1993; 36: 1137-1141.
4. Ihn H, Sato S, Fujimoto M, et al. Clinical significance of serum levels of soluble interelukin-2 receptor in patients with localized scleroderma. Br J Dermatol 1996; 134: 843-847.
5. Fong S, Chen P, Fox R, et al. Rheumatoid factors in autoimmune diseases: their origin, development and function. Pathol immunopathol Res 1986; 5: 305-316.
6. Mizouchi T. [Significance of measurement of rheumatoid factor oligosaccaride for early rheumatoid arthritis.] Rheumati Ka 1994; 112: 337-343 (in Japanese).
7. Parekh RB, Dwek RA, Sutton BJ, et al. Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG. Nature 1985; 316: 425-427.
8. Parekh RB, Isenburg D, Rook G, et al. A comparative analysis of disease associated changes in the galactosylation of serum IgG. J Autoimmun 1989; 2: 101-114.
9. Sumar N, Bodman KB, Rademacher TW, et al. Analysis of glycosylation changes in IgG using lectins. J Immunol Meth 1990; 131: 127-136.
10. Soltys AJ, Hay FC, Bond A, et al. The binding of synovial tissue-derived human monoclonal immunoglobulin G preparations of differing galactose content. Scand J Immunol 1994; 40: 135-143.
11. Takubo N, Yamamoto T, Tanaka S, et al. [The clinical usefulness of the serum anti-agalactosyl IgG antibody values in the early onset RA.] Rheumati Ka 1997; 17: 228-134 (in Japanese).
12. Kondo S, Mashima T, Kai M, et al. [The study of the serum anti-agalactosyl IgG antibody in early rheumatoid arthritis.] Rinshou Kenkyu 1997; 18: 515-510 (in Japanese).
13. Higami K, Hakoda M, Kotake S. [Elevation of quantative diagnositic kit (p155) for detection of anti-agalactosyl IgG antibodies.] Rheumati Ka 1997; 18: 515-520 (in Japanese).
14. Ichikawa Y, Yamada C, Horiki T, et al. Anti-agalactosyl antibodies and isotype profiles of rheumatoid factors in Sjogren syndrome and rheumatoid arthritis. Clin Exp Rheumatol 1998; 16: 709-715.
15. Yamada Y, Hosoda T, Yoshizawa M, et al. [Development and evaluation of the lectin-enzyme immunoassay kit for detection of anti-agalctosyl IgG antibodies.] Kiso Rinsho 1997; 31: 81-101 (in Japanese).
16. Ihn H, Sato S, Tamaki T, et al. Clinical evaluation of scleroderma spectrum disorders using a points system. Arch Dermatol Res 1992; 284: 391-395.
17. Takehara K, Kikuchi K, Soma Y, et al. Anti-single strand DNA antibody and muscle involvement in localized scleroderma. Arch Dermatol 1990; 126: 1368-1369.
18. Ihn H, Sato S, Fujimoto M, et al. Demonstration of interleukin-2, interleukin-4 and interleukin-6 in sera from patients with localized scleroderma. Arch Dermatol Res 1995; 287: 193-197.
19. Nishijima C, Sato S, Takehara K. Anti-agalactosyl IgG antibodies in sera from patients with systemic sclerosis. J Rheumatol 2001; 28: 1847-1851.